FDA Panel Supports Pfizer Vaccine For Children 5-11

An FDA advisory panel has officially endorsed the Pfizer COVID-19 vaccine for children ages 5-11.

The panel made a unanimous decision on Tuesday, which now goes to the FDA for its final ruling, due sometime in the coming days.

If approved, the vaccine would be a smaller dose than the one given to adults – just 10 micrograms compared to 30 in the full vaccine. Just like the adult vaccine, it would be given in two doses, three weeks apart.

Has your family made a decision on what you’ll do once vaccines are available for younger children? Is there any chance the FDA rejects the panel’s advice?

Subscribe to X96's News!

Get the latest music news, contests and flyaways, and more straight to your inbox with our weekly emails.

* indicates required
To Top